Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05833100 · ClinicalTrials.gov registry record · NA
Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System
A NA study, sponsored by i-SENS.
- Terminated
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT05833100: Clinical Trial NA study, sponsored by i-SENS.
NCT05833100 is a NA study that was terminated before completion, run by i-SENS. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05833100, a NA study, was terminated before completion, sponsored by i-SENS.
- TERMINATED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess the accuracy and usability of the blood glucose meter in untrained participants, both with or without diabetes, as well as those with pre-diabetes.
Primary Outcome
The subject's hematocrit measurement should be within the range of 20-60% for the result to be considered evaluable. Two consecutive measurements are taken, and it determinds the analytical validity of a blood sample by the average value.
Interventions
- DEVICE CareSens PRO GK Blood Glucose/b-Ketone Monitoring system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2023-02-23 |
| Phase | NA |
Why NCT05833100 stopped before completion
NCT05833100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which CareSens PRO GK Blood Glucose/b-Ketone Monitoring system is the first listed.
NCT05833100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05833100 about?
NCT05833100 is a clinical study titled "Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System". The goal of this clinical trial is to assess the accuracy and usability of the blood glucose meter in untrained participants, both with or without diabetes, as well as those with pre-diabetes.
What is the current status of trial NCT05833100?
This trial is currently terminated. It is a NA study. The enrollment target is 76 participants. The study started on 2022-08-15. Estimated completion is 2023-02-23.
What interventions are being tested in trial NCT05833100?
The interventions under investigation include: CareSens PRO GK Blood Glucose/b-Ketone Monitoring system (DEVICE).
Who is sponsoring clinical trial NCT05833100?
This trial is sponsored by i-SENS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05833100's enrollment target sits among peer trials
76 1062nd of 2000 higher than 932 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI